Congratulations to 2 lab members who have retired from our group. Yun Wang and Ms Carmen White. Thanks for their dedication to work and teaching of new generation of researchers @jesslin23.bsky.social @giaconajohn.bsky.social

Excellent overview in The Washington Post on the systemic impact of sustained hypertension — from LVH to CKD and cognitive decline. Kudos to Drs. @drwanpen.bsky.social , John B, and @jordybc.bsky.social for evidence base insight. 🔗 www.washingtonpost.com/wellness/202... #Hypertension #Cardiology

New analysis led by our PhD candidate @robynwei.bsky.social shows ⬇️ salt substitute use among US adults, Not good for BP. 🚫 real salt @giaconajohn.bsky.social @jesslin23.bsky.social @utswim.bsky.social @jongarinn.bsky.social ahajournals.org/doi/10.1161/...

Our new paper @jesslin23.bsky.social showing low accuracy when eyeballing BP log and more importantly may lead to failure to start or ⬆️BP meds in HTN. Thanks 🙏all faculty&trainees for helping us @utswim.bsky.social www.ahajournals.org/doi/full/10.... @robynwei.bsky.social @giaconajohn.bsky.social

Such a blast as always! But now I want a burrito 🌯

Good HTN journal club today by @robynwei.bsky.social discuss effects of ultraprocessed food on cardiometabolic health @giaconajohn.bsky.social @hkkimphd.bsky.social Need to eat less UPF! www.nature.com/articles/s41...

great HTN JC discussion today on BAXHTN study by Dr. Shawna Nesbitt joined by @dramitkhera.bsky.social @giaconajohn.bsky.social @utswim.bsky.social Interesting that baseline aldosterone in the trial was around 7.5 ng/dL by LCMS with baseline PRA is 1 ng/mlhr. This means that majority of pts have PA

🏆 First time at Epic Cosmos Datathon—our team took 1st place! Grateful for the collaboration and hands on experience ! @drwanpen.bsky.social Excited to present tomorrow (Oct 3) at Pegasus Park Symposium on “Missed Opportunities: Screening for Primary Aldosteronism” #EpicCosmos #HTN

Excellent commmentary from @giaconajohn.bsky.social and @drwanpen.bsky.social

Comparing Management strategies for Primary Aldosteronism: Is it 🍎 versus 🍊 ? Commentary academic.oup.com/ajh/article-... based on academic.oup.com/ajh/article-... #Hypertension #Aldosteronism

Subclinical primary aldosteronism is an under-recognized driver of cardiovascular risk. Could it be a new target for CV prevention? Read our Circulation editorial —>

Our new study that links high Phosphate diet found in processed food and anxiety behavior and alternation of genes involved in mood regulation in mice. That may explain why we don't feel good after a whopper or a big Mac @hkkimphd.bsky.social @utswim.bsky.social sciencedirect.com/science/arti...

great HTN journal club discussing GWAS in primary aldosteronism by @jdmosley-moses.bsky.social @giaconajohn.bsky.social www.ahajournals.org/doi/10.1161/...

So much fun AHA #Hypertension25 gala dinner learning history of HTN from Bill Cushman and visiting with friends @anastasiasmihaili.bsky.social @giaconajohn.bsky.social @spjuraschek.bsky.social

@giaconajohn.bsky.social excellent talk highlights that intensive lowering of BP leads to lower not higher risk of OH based on metaanalysis of RCT by @spjuraschek.bsky.social #Hypertension25 Rx should be titrated to seated BP in OH as per 2025 high BP guidelines

Efficacy and Safety of Baxdrostat in Participants with CKD and Uncontrolled #Hypertension: A Randomized, Double-Blind, Placebo-Controlled Trial ca. 2025 from @asnpublications.bsky.social @escardio.bsky.social #Nephpearls #NephSky #ESCCongress 👉 journals.lww.com/jasn/fulltex...

Great dinner celebrating #Hypertension25 together near harbor with UTSW group Angie Price @giaconajohn.bsky.social @robynwei.bsky.social @jesslin23.bsky.social and Mu Huang

Dr Karol Watson starts with impactful message top 10 take away message #Hypertension25 high BP as predictor dementia and treatment reduces cognitive decline or dementia by 15% . Once you hit 120/80 , trajectory to high BP is steep. Don’t sit on high BP! @ahascience.bsky.social

Ideal BP < 120/80 mmHg! #Hypertension25

Congratulations @robynwei.bsky.social RD/ PhD candidate for her poster #Hypertension25 highlighting underutilization of salt substitute use in the US @giaconajohn.bsky.social details in AHA News release newsroom.heart.org/news/u-s-sur... @ahascience.bsky.social

Honored to present my abstract poster at the AHA #hypertension25 on the prevalence of salt substitute use. Grateful that our work @drwanpen.bsky.social @giaconajohn.bsky.social @jesslin23.bsky.social was also featured in the official AHA news release: newsroom.heart.org/news/u-s-sur...

Kicked off the day with a run around Baltimore Harbor 🌊🏃‍♂️ at #Hypertension25. A reminder that movement matters — let’s keep championing lifestyle and physical activity as powerful tools to reduce CVD and BP! @ahascience.bsky.social

Outstanding review of resistant hypertension at #HTN25 by Drs. @drwanpen.bsky.social , Keith Ferdinand, and Ty Gluckman — from current challenges in care to exciting new agents in the pipeline. Great insights into where the field is heading!

Thank you to AHA for the opportunity to present at AHA HTN scientific session 25 in Baltimore. Having an amazing time meeting and connecting with experts in the field! @drwanpen.bsky.social @giaconajohn.bsky.social @robynwei.bsky.social

Great talk #Hypertension25 by @jesslin23.bsky.social in discussing limitations of visual estimation of home BP in clinical decision in Rx HTN in Eyeball study @robynwei.bsky.social @giaconajohn.bsky.social

Fantastic opening session at AHA #HTN25 — great energy, insights, and inspiration already flowing. Excited for the great science and rich discussions ahead! @ahascience.bsky.social @drwanpen.bsky.social

Got to Baltimore #Hypertension25 so excited to see friends and colleagues talking about high BP ! @ahascience.bsky.social @giaconajohn.bsky.social

❓What’s new in BP care? 🎥 Watch the #TargetBP webinar on the 2025 @AHAScience / @ACCinTouch Hypertension Guidelines w/ @drwanpen.bsky.social , @jordybc.bsky.social , Keith Ferdinand, & Dan Jones 👉 targetbp.org

Join us @jordybc.bsky.social , Keith Ferdinand, and Dan Jones unpacking 2025 AHA/ACC guidelines on Thursday Aug 28 bit.ly/Guideline25W... @UTSWInternalMed @utswheart

New 2025 AHA/ACC Hypertension Guidelines are out! You will not want to miss this webinar! Sign up 👇

Another great HTN JC by @giaconajohn.bsky.social on AVIM therapy, which just received BDD status. A niche pacemaker for pt with systolic HTN but concerns remain for reduced cardiac output from AV dyssynchrony+ chronic RV pacing. with this high BP variability, how can oscillometric BP be accurate?

Our latest clinical practice guideline, Primary Aldosteronism (bit.ly/44MbrSv), is now available. The new guideline recommends more widespread screening for a common hormonal cause of high blood pressure known as primary aldosteronism. Read in @endocrinenews.bsky.social: bit.ly/4kFadhv #ENDO2025

A medical adrenalectomy? ASIs advance - Baxdrostat in primary aldosteronism now www.nejm.org/doi/full/10.... n = 15 single arm trial from @adinaturcu.bsky.social and @astra-zeneca.bsky.social in @nejm.org ~ 25/10 mm Hg BP lowering and impressive aldosterone level drop #Hypertension #EndoSky

New PA Endo guideline is also out by experts @anandvaidya17.bsky.social #Cardiosky @hswapnil.medsky.social doi.org/10.1210/clin...

In 15 patients with primary aldosteronism, baxdrostat (a second-generation, nonimidazole aldosterone synthase inhibitor) resolved or reduced the severity of hypertension, excessive aldosterone production, and hypokalemia. Full SPARK study results: nej.md/40Js1kz #ENDO2025

Another fun Hypertension JC today. Bedmed trial was disccused by Jesslin Abraham our fellow. @giaconajohn.bsky.social @hkkimphd.bsky.social @utswim.bsky.social

Yes! Such a great JC! Loved the multidisciplinary insights

The first #ERA25 simultaneous pub CONFIDENCE trial of empagliflozin + finerenone in N = 579 Greater reduction in ACR and BP Note the impressive GFR dip www.nejm.org/doi/full/10....

Our new paper led by @hkkimphd.bsky.social published today in Circulation that highlights hypertension induced by dietary phosphate excess via FGF23-FGFR4-calcineurin activation of SNS in normal rats bit.ly/43H3cGB @ahascience.bsky.social #cardiosky

Although it is getting warmer in Dallas, red Asiatic Lillies seem to enjoy it in my backyard. #magicalgarden

The ACC has named Viet Le, DMSc, MPAS, PA-C, FACC, to lead its #CardioSmart patient engagement program. "I'm excited to build on my predecessors' work, providing tools for informed decisions & supporting healthy life journeys." - @vietheartpa.bsky.social More: bit.ly/44UY5VN #CardioSky #MedSky

Don’t forget that 20-30% of patients with RHTN have primary aldosteronism. These patients get extrarenal, BP-independent benefits from MR-blockade. So be sure PA is excluded before reaching for amiloride. #nephsky

Great to visit with friends @k-bunsawat.bsky.social #APS2025 Congrats Ayumi Fukazawa for receiving Henry Pickering abstract recognition!

Super interesting work by Dr Vongpatanasin on SGLT2i mechanisms of lowering BP - possibly by decreased renal sympathetic nerve activity independent of glycemic control @drwanpen.bsky.social @nkf-professionals.bsky.social @spjuraschek.bsky.social www.ahajournals.org/doi/10.1161/...

A nice package from AMA today. Grateful to be part of validatebp.org group w Tammy Brady @jordybc.bsky.social @spjuraschek.bsky.social who are serious about certifying good BP monitors for public use. Please check validatebp.org website before spending your money on new BP monitors! #cardiosky

Proud of our PhD student Robyn Wei (also a registered dietician) who present an abstract at our UTSW WISMAC today on salt taste perception and acceptance to salt substitute in a blinded salt taste challenge study. Glad to find out that I prefer SS to regular salt ! @giaconajohn.bsky.social

Glad to discuss HTN center model #ACC25. History of HTN is UTSW is rich from Dr. Norman Kaplan to Ron Victor. The room is packed with standing room on. Dr. Commodore-Mensah discuss challenge in doing Health Equity research in the new era. Dr. Ferdinand discuss new drugs in HTN

Fantastic talk by Mark Supiano at IM Grand Rounds this morning highlighting benefits of intensive BP control on cognitive outcomes in older adults from RCTs. Better yet, Legacy effect of SPRINT BP control on MCI and dementia. #Cardiosky #Nephsky @k-bunsawat.bsky.social

Congratulations Dr. Han Kim for identifying augmented exercise pressor reflex ⬆️ renal sympathetic nerve and BP response to exercise in the rat model of CKD #Cardiosky #Nephsky ow.ly/IywH50VeKqx